Clinical Trials
3 trialsNCT07044310 2025-07-29
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic
Phase 2 Recruiting
NCT00842465 2013-11-25
Prolacsein
Assistance Publique - Hôpitaux de Paris
Completed
NCT00587925 2009-02-26
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed